IL1A and rheumatoid arthritis: Currently, although products such as IL-1 antagonists, TNF inhibitors and anti-IL-6 receptor antibody are effective in RA treatment, not all the RA patients respond to these cytokine associated products, and none of these drugs are curative for RA [6].